Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Monday, February 6, 2023 · 615,366,353 Articles · 3+ Million Readers

Biosimilar Hormones Market Size Expected To Reach $7.68 Billion By 2027

Biosimilar Hormones Market Report 2023 – Market Size, Trends, And Market Forecast 2023-2032

Biosimilar Hormones Global Market Report 2023 – Market Size, Trends, And Market Forecast 2023-2032

The Business Research Company’s Biosimilar Hormones Global Market Report 2023 – Market Size, Trends, And Market Forecast 2023-2032

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032”
— The Business Research Company

LONDON, GREATER LONDON, UK, January 24, 2023 / -- The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s “Biosimilar Hormones Global Market Report 2023” is a comprehensive source of information that covers every facet of the Biosimilar Hormones market. As per TBRC’s biosimilar hormones market forecast, the biosimilar hormones market size is predicted to reach a value of $7.68 Billion by 2027, rising at a significant annual growth rate of 26.2 percent through the forecast period.

The growth in the biosimilar hormones market is due to the prevalence of deficiencies in growth hormones and metabolic hormones. North America region is expected to hold the largest biosimilar hormones market share. Major players in the biosimilar hormones market include Teva Pharmaceutical, Gedeon Richter, Intas Pharmaceuticals, Biocon, Mylan.

Learn More On The Biosimilar Hormones Market By Requesting A Free Sample (Includes Graphs And Tables):

Trending Biosimilar Hormones Market Trend
Key players operating in the biosimilar hormones market are undertaking various strategic initiatives such as new product launches in untapped regions to make the drug accessible to a large population. The companies are focusing on launching their products in various locations to boost sales and maximise profits. For instance, in February 2022, Alvotech Holdings S.A., a Luxembourg-based biopharmaceutical company specialising in the development of biosimilar medicines, announced partnerships with Fuji Pharma Co. Ltd., a Japan based pharmaceutical company, to develop biosimilar drug candidates in Japan. Through this partnership, both companies have decided to add new elements to their strategic alliance for the creation and marketing of biosimilar medicines in Japan.

Biosimilar Hormones Market Segments
•By Type: Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Other Types
•By Application: Research & Biotechnology, Diagnostics, Biocatalysts, Therapeutics, Other Applications
•By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/e-pharmacy, Specialty Clinics
•By Geography: The global Biosimilar Hormones market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read more on the global Biosimilar Hormones market report at:

Biosimilar hormones refer to the hormones included in the product that are chemically identical to those produced by your body. In fact, it's possible that the hormones in bioidentical drugs are identical to those used in conventional hormone therapy. They are used to treat people whose hormone levels are low or out of whack.

Biosimilar Hormones Global Market Report 2023 from TBRC covers the following information:
•Market size date for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Biosimilar Hormones Global Market Report 2023 by The Business Research Company is the most comprehensive report that provides insights on biosimilar hormones global market size, drivers and trends, biosimilar hormones global market major players, competitors' revenues, market positioning, and biosimilar hormones global market growth across geographies. The biosimilar hormones global market analysis helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Branded Generics Global Market Report 2022

Parathyroid Hormone Global Market Report 2023

Hormonal Contraceptives Market 2022

About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Check out our:
Healthcare Blog:
Global Market Model:

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:

Powered by EIN Presswire

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release